Massive donor transfusion potentially increases recipient mortality after lung transplantation

Area of Science:

• Transplantation Medicine
• Immunology
• Critical Care

Background:

• Donor blood transfusion is a suspected risk factor for primary graft dysfunction and early mortality in lung transplant recipients.
• Understanding the specific impact of donor transfusion volume on post-transplant outcomes is crucial for improving patient survival.

Purpose of the Study:

• To determine the association between donor blood transfusion volume and early mortality following lung transplantation.
• To investigate if massive donor transfusions pose a greater risk than lower volumes.

Main Methods:

• Analysis of donor and recipient data from the Organ Procurement and Transplantation Network database (up to June 30, 2014).
• Inclusion of 16,255 lung transplants, categorizing donor transfusion into four levels (none, 1-5 units, 6-10 units, >10 units).
• Logistic regression analysis adjusted for confounders to assess 30-day, 90-day, and 1-year all-cause mortality.

Main Results:

• Over 54% of donors received at least one transfusion; 6.25% received massive transfusions (>10 units).
• Massive donor transfusion was significantly associated with increased 30-day (P=.03) and 90-day (P=.01) recipient mortality.
• No significant association was found between donor transfusion volume and 1-year mortality or hospital length of stay.

Conclusions:

• Massive donor blood transfusion (>10 units) is linked to higher early mortality after lung transplantation.
• Submassive donor transfusions do not appear to increase recipient mortality risk.
• The underlying mechanisms for increased early mortality associated with massive donor transfusions require further investigation.